Pudong, China

Wei Guo

This inventor holds 2 USPTO granted patents. Top assignees: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Guo. Retrieved from https://idiyas.com/inventor/wei-guo-suv1zzhd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wei Guo: Innovator in Antibody Research

Introduction

Wei Guo is a prominent inventor based in Pudong, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of antibodies. His work is crucial for advancing medical treatments and therapies.

Latest Patents

Wei Guo holds a patent titled "Antibody Binding to Human CD38, Preparation Method Thereof, and Use Thereof." This patent represents his innovative approach to targeting human CD38, which is essential in various therapeutic applications.

Career Highlights

Wei Guo is currently employed at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His role at the company allows him to apply his expertise in antibody research and contribute to the development of new pharmaceutical products.

Collaborations

Wei Guo has collaborated with notable colleagues, including Haomin Huang and Zhenping Zhu. These partnerships enhance the research and development efforts within the pharmaceutical industry.

Conclusion

Wei Guo's contributions to antibody research and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the pharmaceutical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…